Skip to main content

Table 1 Demographic data (n = 40 patients)

From: Dexmedetomidine is effective and safe during NIV in infants and young children with acute respiratory failure

Variables Median (IQR)
Age (months) 16 (6,50-33,50)
Weight (kg) 12 (6,2–17)
Gender (M/F) 30/10
PRSIM III 24 15,50 (12–22)
Niv Duration (hours) 48 (36;96)
PICU LOS (days) 7 (5–18,7)
PO2/FiO2 Ratio at NIV onset 175 (150–203)
Main diagnosis
 Bronchiolitis 12 (30%)
 ARDS 7 (17,5%)
 Chest trauma 2 (5%)
 Burn-associated Respiratory Failure 4 (10%)
 Status Asthmaticus 3 (7,5%)
 Neurological illness 3 (7,5%)
 Pneumonia 4 (10%)
 Bronchopulmonary Dysplasia 3 (7,5%)
 Post-operative patients 2 (5%)
NIV Interfaces
 Helmet 12 (30%)
 Total Face Mask 11 (27,5%)
 Nasal Mask 17 (42,5%)
  1. NIV Non Invasive Ventilation, PICU LOS Pediatric intensive Critical Unit length of stay, ARDS acute respiratory distress syndrome